About our Inflammatory Bowel Disease news
Latest news on inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis - symptoms, causes, treatments, research, and patient stories.
IBD affects over 10 million people worldwide. It is characterized by chronic inflammation of the gastrointestinal tract, leading to symptoms like abdominal pain, diarrhea, weight loss, and fatigue. Crohn's disease and ulcerative colitis are the two main types of IBD.
In a breakthrough discovery reported in Nature in June 2024, UK scientists identified a genetic weak spot present in 95% of IBD patients that allows certain immune cells to trigger excessive gut inflammation. Drugs targeting this pathway showed promise in lab experiments. Clinical trials could start within 5 years, offering hope for better IBD treatments.
Beyond medical advances, our IBD news feed covers practical matters like managing symptoms, patient support groups, and inspiring stories of people thriving despite IBD challenges. We highlight community events that raise IBD awareness and feature leading IBD charities like Crohn's & Colitis UK.
While the causes of IBD remain unclear, research suggests a combination of genetic predisposition, immune system malfunction, and environmental triggers. Notable risk factors include family history, smoking, and possibly diet. Over the past century, IBD prevalence has risen sharply, especially in industrialized nations, for reasons that continue to be investigated.
For comprehensive, up-to-date information on inflammatory bowel disease, our NewsNow IBD feed gathers the most relevant headlines from expert sources you can trust. It's an invaluable resource for everyone affected by or interested in IBD - patients, families, healthcare providers, researchers, and the wider public. With regular updates on the latest developments, you can rely on our IBD news feed to keep you fully informed.